08

Shanghai Fosun Pharmaceutical Group Co LtdDUS Shanghai Fosun Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Oct, 2024

Last price

Market cap $B

7.802

Middle

Exchange

XDUS - Boerse Duesseldorf

View Section: Company Analysis

Shanghai Fosun Rating

08

08HH.DU stock rating score is 15/100. Shanghai Fosun is aExtremely Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

Last update 09.09.2024

15/100

Low score

Rating Breakdown

  • Profitability score

    23

    /25

  • Solvency score

    4

    /25

  • Efficiency score

    2

    /25

  • Stability score

    -14

    /25

Shanghai Fosun Pharmaceutical Group Co Ltd Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

4 %

Earnings quality

212 %

Gross Margin

46 %

Shanghai Fosun Pharmaceutical Group Co Ltd's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation